Oxidized LDL-induced NF-κB activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 8, 2000, Pages 1953-1960

  Janabi, Mohamed ^a   Yamashita, Shizuya ^a   Hirano, Ken Ichi ^a   Sakai, Naohiko ^a   Hiraoka, Hisatayo ^a   Matsumoto, Kengo ^a   Zhang, Zhongyan ^a   Nozaki, Shuichi ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; CD36; Cytokines; Monocyte derived macrophages; Oxidized LDL

Indexed keywords

BETA INTERFERON; CD36 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LYMPHOTOXIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR; THROMBOSPONDIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CYTOKINE RELEASE; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION; GENE INDUCTION; HUMAN; LIPID TRANSPORT; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033847712     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.8.1953     Document Type: Article

References (29)

1. A comparison of the Framingham risk index, coronary artery calcification, and culprit plaque morphology in sudden cardiac death
2. The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters
3. Atherosclerosis: An inflammatory disease
4. Lipoprotein trafficking in vascular cells
5. Engagement of the Lewis X (CD15) results in monocyte activation
6. Function activation of NF-κB in immune system
7. Genetic evidence for common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice
8. The influence of oxidatively modified low density lipoproteins on expression of PDGF by human monocyte-derived macrophages
9. Activation of interleukin-6 gene expression through the NF-κB transcription factor
10. Iron and copper promote modification of low-density lipoprotein by arterial smooth muscle cells in culture
11. Protein measurement with the Folin phenol reagent
12. Preparation of quiescent human monocytes for studies of colony stimulating factor responsiveness
13. The type-1 repeats of thrombospondin-1 activate latent transforming growth factor-β
14. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor
15. Phorbol-ester induced activation of the NF-κB transcription factor involves dissociation of an apparently cytoplasmic NF-κB/inhibitor complex
16. Expression cloning of SR-BI, a CD36-related class B scavenger receptor
17. Expression of macrophage scavenger receptors in various human tissues and atherosclerotic lesion
18. CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta
19. Reduced uptake of oxidized low density lipoprotein in monocyte-derived macrophages from CD36-deficient subjects
20. Regulation of interleukin 1 gene expression by adherence and lipopolysaccharide
21. Oxidized low density lipoprotein increases, and interferon-γ, decreases, the expression of CD36 in human monocyte-derived macrophages
22. Human monocyte CD36 and CD16 are signaling molecules: Evidence from studies using antibody-induced chemiluminescence as a tool to probe signal transduction
23. CD14-mediated translocation of nuclear factor-κB induced by lipopolysaccharide does not require tyrosine kinase
24. The carboxyl-terminal cytoplasmic domain of CD36 is required for oxidized low-density lipoprotein modulation of NF-κB activity by tumor necrosis factor-α
25. Activation of rat alveolar macrophage-derived latent TGFβ-1 by plasmin requires interaction with TSP-1 and its cell surface receptor, CD36
26. PPAR-γ promoted monocyte/macrophage differentiation and uptake of oxidized LDL
27. Impaired production of tumor necrosis factor in breast cancer
28. Different patterns of 1231-BMIPP myocardial accumulation in patients with type I and II CD36 deficiency
29. Absent myocardial iodine-123-BMIPP uptake and platelet/monocyte CD36 deficiency